IE
BCDA icon

Israel Englander’s BioCardia BCDA Stock Holding History

Israel Englander’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-769
Closed -$24K – 6361
2022
Q4 		$24K Sell
769
-667
-46% -$19K ﹤0.01% 5996
2022
Q3 		$42K Sell
1,436
-451
-24% -$11.7K ﹤0.01% 6235
2022
Q2 		$42K Buy
+1,887
New +$45.2K ﹤0.01% 6254
2021
Q4 		– Sell
-668
Closed -$31K – 6786
2021
Q3 		$31K Buy
+668
New +$32.8K ﹤0.01% 6633
2020
Q3 		– Sell
-1,151
Closed -$41K – 4441
2020
Q2 		$41K Sell
1,151
-994
-46% -$53.8K ﹤0.01% 4060
2020
Q1 		$104K Sell
2,145
-2
-0.1% -$124 ﹤0.01% 3542
2019
Q4 		$118K Sell
2,147
-652
-23% -$38.3K ﹤0.01% 3999
2019
Q3 		$138K Buy
+2,799
New +$201K ﹤0.01% 3891

Other funds holding BCDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FM
Family Management New York $975M AUM 23.16% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Israel Englander's BCDA Position: Q1 2023 in Review

Israel Englander sold out of BioCardia (BCDA) in Q1 2023, closing a stake of 769 shares — an estimated $24K sold.

Israel Englander first reported a position in BCDA in Q3 2019 and held it in 8 quarters. The position peaked at $138K in Q3 2019. 23 funds tracked by Wall St. Rank hold BCDA as of Q1 2023.

  • Israel Englander reported no remaining BioCardia position as of Q1 2023 after selling out during the quarter.
  • Israel Englander sold 769 BioCardia shares in Q1 2023, an estimated $24K.
  • Israel Englander first reported a position in BioCardia in Q3 2019 and held it in 8 quarters.
  • Israel Englander's BioCardia position peaked at $138K in Q3 2019.
  • 23 funds tracked by Wall St. Rank held BioCardia as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.